LIPO-202
Showing 1 - 25 of 168
Central Abdominal Bulging Trial (LIPO-202, Placebo)
Terminated
- Central Abdominal Bulging
- LIPO-202
- Placebo
- (no location specified)
Nov 25, 2019
Central Abdominal Bulging Trial in United States (LIPO-202, Placebo)
Completed
- Central Abdominal Bulging
- LIPO-202
- Placebo
-
Birmingham, Alabama
- +34 more
Jan 4, 2019
Metabolic Syndrome Trial in Québec (INV-202, Placebo)
Completed
- Metabolic Syndrome
- INV-202
- Placebo
-
Québec, Quebec, CanadaSyneos Health Clinique Inc
Oct 3, 2022
Duchenne Muscular Dystrophy Trial in Little Rock (RGX-202)
Recruiting
- Duchenne Muscular Dystrophy
- RGX-202
-
Little Rock, ArkansasArkansas Children's Hospital
Jan 12, 2023
Healthy Volunteers, Mild to Moderate Psoriasis Trial in Manchester (Placebo, AX-202)
Recruiting
- Healthy Volunteers
- Mild to Moderate Psoriasis
- Placebo
- AX-202
-
Manchester, Wythenshawe, United KingdomMedicines Evaluation Unit
Jul 19, 2023
Skin Laxity Trial in New York (TempSure treatment)
Completed
- Skin Laxity
- TempSure treatment
-
New York, New YorkJUVA Skin & Laser Center
May 27, 2022
Influenza, Human, Infections, Respiratory Tract Infections Trial in United States (aH5N8c on Day 1, aH5N6c on Day 1, aH5N8c on
Not yet recruiting
- Influenza, Human
- +4 more
- aH5N8c on Day 1
- +4 more
-
Cullman, Alabama
- +8 more
May 15, 2023
Obesity, Life Style, Healthy, Follow-up Trial in Odense (Lifestyle intervention Dietary advise and/or advise on physical
Not yet recruiting
- Obesity
- +4 more
- Lifestyle intervention Dietary advise and/or advise on physical activity
-
Odense, DenmarkSteno Diabetes Center Odense
Mar 21, 2023
Jansky-Bielschowsky Disease, Batten Disease, Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2 Trial in Worldwide (BMN 190,
Completed
- Jansky-Bielschowsky Disease
- +4 more
- BMN 190
- Intracerebroventricular (ICV) access device
-
Columbus, Ohio
- +3 more
Jul 28, 2022
Pulmonary Arterial Hypertension Trial (Treprostinil Palmitil, Placebo)
Not yet recruiting
- Pulmonary Arterial Hypertension
- Treprostinil Palmitil
- Placebo
- (no location specified)
Dec 6, 2022
Colorectal Cancer, Metastatic Colon Cancer Trial (Ompenaclid (RGX-202-01) + FOLFIRI + Bevacizumab, Placebo + FOLFIRI +
Not yet recruiting
- Colorectal Cancer
- Metastatic Colon Cancer
- Ompenaclid (RGX-202-01) + FOLFIRI + Bevacizumab
- Placebo + FOLFIRI + Bevacizumab
- (no location specified)
Aug 1, 2023
Tricuspid Valve Regurgitation, Heart Valve Diseases, Cardiovascular Diseases Trial in Japan (Edwards EWJ-202 Transcatheter
Recruiting
- Tricuspid Valve Regurgitation
- +2 more
- Edwards EWJ-202 Transcatheter Tricuspid Valve Replacement System
-
Kitakyushu-shi, Fukuoka, Japan
- +6 more
Feb 27, 2023
Lipo-transfer Cannulas in Patients Underlying Lipofilling
Recruiting
- Lipodystrophy
- Deformities
-
Brest, France
- +2 more
Oct 17, 2023
Delayed Breast Reconstruction by Prepectoral Implant After
Active, not recruiting
- Breast Cancer Female
- Breast reconstruction
-
Saint-Herblain, FranceInstitut de Cancérologie de l'Ouest René Gauducheau
Mar 10, 2022
Human Papilloma Virus, HPV, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Chicago (HB-201, HB-202, Carboplatin)
Recruiting
- Human Papilloma Virus
- +3 more
- HB-201
- +4 more
-
Chicago, IllinoisUniversity of Chicago
Aug 11, 2022
Gastric Cancer, Small-cell Lung Cancer Trial in China, Korea, Republic of, Taiwan (EP0057, Olaparib tablets)
Not yet recruiting
- Gastric Cancer
- Small-cell Lung Cancer
- EP0057
- Olaparib tablets
-
Shanghai, Changning District, 交通大学 邮政编码, China
- +20 more
Nov 1, 2022
Influenza, Human Trial (sa-mRNA vaccine Dose 1, sa-mRNA vaccine Dose 2, sa-mRNA vaccine Dose 3)
Not yet recruiting
- Influenza, Human
- sa-mRNA vaccine Dose 1
- +4 more
- (no location specified)
Sep 7, 2023
Solid Tumor, Adult Trial in United States (IO-202, IO-202 + pembrolizumab combination therapy, RP2D of IO-202 + pembrolizumab
Not yet recruiting
- Solid Tumor, Adult
- IO-202
- +2 more
-
Los Angeles, California
- +3 more
Mar 25, 2022
Contact Lens Complication Trial in Valladolid (Aquoral Lipo (Esteve), Hyabak (Thea))
Recruiting
- Contact Lens Complication
- Aquoral Lipo (Esteve)
- Hyabak (Thea)
-
Valladolid, SpainIOBA - University of Valladolid
Nov 28, 2022
Advanced Solid Tumor, Lymphoma Trial in United States (ALPN-202, Pembrolizumab)
Active, not recruiting
- Advanced Solid Tumor
- Lymphoma
-
Atlanta, Georgia
- +4 more
Nov 8, 2022